In this study, six clinical isolates (two from blood, two from urine and one each from a bronchoalveolar lavage and a vaginal swab) were identified as Candida rugosa based on carbohydrate assimilation profiles using API 20C AUX and ID32 C kits (bioMé rieux). Sequence analysis of the D1/D2 domain of the yeasts differentiated the isolates into two subgroups, A and B (three isolates per subgroup), which were closely related (99.1-99.6 % nucleotide similarity) to C. rugosa strain ATCC 10571. Compared with the C. rugosa type strain, the intergenic transcribed spacer (ITS) nucleotide similarity for subgroup A was only 89.2 % (29 mismatches and one deletion) and for subgroup B was 93.7 % (20 mismatches). All isolates grew green colonies on Oxoid Chromogenic Candida Agar, with darker pigmentation observed for subgroup A. All isolates were able to grow at 25-42 6C but not at 45 6C. The isolates had identical enzymic profiles, as determined by API ZYM (bioMé rieux) analysis, and produced proteinase. High amphotericin MICs (¢1 mg ml "1 ) were noted for two isolates from each subgroup. Dosedependent susceptibility to fluconazole (MIC 32 mg ml "1 ) was noted in a blood isolate. The biofilms of the isolates demonstrated increased resistance to amphotericin and fluconazole. The greater ITS sequence variability of subgroup A isolates is in support of this yeast being recognized as a distinct species; however, further verification using more sophisticated molecular approaches is required. A sequence comparison study suggested the association of subgroup A with environmental sources and subgroup B with clinical sources. Accurate identification and antifungal susceptibility testing of C. rugosa are important in view of its decreased susceptibility to amphotericin and fluconazole. The ITS region has been shown to be a valuable region for differentiation of closely related subgroups of C. rugosa.
INTRODUCTION
Candida rugosa has been recognized as an emerging fungal pathogen capable of causing invasive infection in immunocompromised patients. This yeast has been identified as a rare cause of bloodstream infections in North America and Europe (Minces et al., 2009 ) and accounted for 0.4 % of Candida isolates in the global ARTEMIS DISK Antifungal Surveillance Program (Pfaller et al., 2006) . However, it has been noted with increased frequency of isolation in several geographical regions recently. C. rugosa has been identified as a frequent colonizer of high-risk patients and accounted for 44 % of 32 consecutive episodes of candidaemia in critically ill Brazilian patients (Colombo et al., 2003; Rosas et al., 2004) . In a laboratory-based surveillance study in India, C. rugosa was the predominant Candida species isolated from the blood cultures of .20 % of critically ill trauma patients (Behera et al., 2010; Singh et al., 2011) .
The existence of genetic heterogeneity in C. rugosa isolates has been documented in a previous study where clinical isolates were clustered into nine fingerprinting groups using a repetitive sequence-based PCR technique (Redkar et al., 1996) . Recently, a novel yeast species closely related to C. rugosa, Candida pseudorugosa, exhibiting a similar API 20C AUX carbohydrate assimilation profile to C. rugosa, has been reported (Li et al., 2006) . Reports on the association of C. rugosa with catheters and total parenteral nutrition, nosocomial spread and decreased susceptibility to both polyenes and fluconazole (Dubé et al., 1994; Minces et al., 2009) have made identification and characterization of this emerging yeast pathogen important.
Molecular methods based on sequencing of the 26S rRNA gene D1/D2 domain or intergenic transcribed spacer (ITS) region and use of carbohydrate assimilation profiling and chromogenic Candida agar are helpful for the correct identification of clinical isolates of yeast when routine phenotypic methods are insufficient (Ciardo et al., 2006; Kurtzman & Robnett, 1997) . To validate the identity of our isolates, phenotypic and molecular approaches including enzymic analysis were applied. The antifungal susceptibilities of the planktonic and sessile cells of these isolates are also presented in this study.
METHODS
Yeast isolates. Table 1 shows the origin and details of six yeast isolates (strains STC1-6), which were initially identified as C. rugosa by API 20C AUX tests (code 6442104; bioMérieux) in this study. The yeasts were obtained from blood (n52), urine (n52), a vaginal swab (n51) and a bronchoalveolar lavage (n51) from six independent inpatients at the University of Malaya Medical Center, Kuala Lumpur, Malaysia, from 2005 to 2007. The yeasts were inoculated onto potato dextrose agar and incubated at 25, 30, 35, 42 and 45 uC for up to 7 days. Chromogenic testing of the isolates was performed on Oxoid Chromogenic Candida Agar (OCCA). An ID32 C kit (bioMérieux) was used for further identification of the yeast strains, following the manufacturer's instructions.
Enzymic profiling of C. rugosa. API ZYM (bioMérieux) analysis was used to define the enzymic profiles of the yeasts, as recommended by the manufacturer. A proteinase agar clearance assay was performed according to the method of Ruma-Haynes et al. (2000) .
Sequence determination and analysis. Yeast genomic DNA was extracted as described by Makimura et al. (1994) . The ITS region and the 26S rRNA gene D1/D2 domain were amplified with primer pair ITS1 (59-GTCGTAACAAGGTTTCCGTAGGTG-39) and ITS4 (59-TCCTCCGCTTATTGATATGC-39) (White et al., 1990) and primer pair NL1 (59-GCATATCAATAAGCGGAGGAAAAG-39) and NL4 (59-GGTCCGTGTTTCAAGACGG-39), respectively (Kurtzman & Robnett, 1997) . The amplicon was purified using a PCR SV kit (GeneAll) and the subsequent sequencing reaction was performed with a Big Dye Terminator version 3.1 Cycle Sequencing kit (Applied Biosystems) on an ABI PRISM 377 Genetic Analyzer (Applied Biosystems), using forward and reverse primers. The sequences were used for a BLAST search in GenBank. The neighbour-joining method in MEGA version 4.0 was used to determine the phylogenetic status of the isolates (Kumar et al., 2004) . The reliability of different phylogenetic groupings was evaluated using bootstrap tests (1000 bootstrap replications). Sequences of C. rugosa isolates (Table 2 ) and reference strains of Candida species were retrieved from GenBank.
Determination of planktonic MICs. The planktonic MICs of amphotericin, fluconazole, ketoconazole and flucytosine for the yeasts were determined using a microbroth dilution method as described by the Clinical and Laboratory Standards Institute (CLSI, 2008) . MICs were recorded after incubation at 35 uC for 48 h. The MIC of amphotericin was defined as the lowest concentration at which there was an absence of growth. The MICs of the other drugs were defined as the lowest drug concentrations that achieved 80 % growth inhibition compared with growth of the drug-free control.
Determination of biofilm formation and MICs. The biofilmforming abilities of the isolates were determined using a standardized method as described by Ramage et al. (2001) . Briefly, an overnight yeast culture was suspended in RPMI 1640 broth supplemented with L-glutamine (Sigma) to a final concentration of 10 7 cells ml 21 (OD 530 of 0.38). An aliquot of 100 ml of the yeast suspension was then transferred to each well of a flat-bottomed, 96-well polystyrene microtitre plate (Nunclon). After incubation with shaking at 75 r.p.m. at 37 uC for 1.5 h, unattached cells were removed by washing twice with 150 ml PBS. Fresh RPMI 1640 (100 ml) was then added to each well to allow proliferation of the biofilm for 24 h. The metabolic activity of the biofilm was measured using a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H-tetrazolium hydroxide (XTT) reduction assay as described by Jin et al. (2003) . The biofilm in each well was washed twice with 200 ml PBS and a solution containing XTT with menadione was added. The A 490 of the resultant solution (100 ml) after incubation for 1 h in the dark was measured with a spectrophotometer. The biofilm MIC was determined as described by Melo et al. (2007) . Biofilms were washed after 24 h, and amphotericin and fluconazole were added at concentrations of 0.015-8 and 0.25-128 mg ml
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, respectively. Two hundred microlitres of each drug solution was added to the respective wells of the microtitre plate and incubated at 37 uC for 48 h. Biofilm MICs were determined on the basis of a 50 % reduction in metabolic activity compared with the activity of the biofilm in the microtitre well without the drug. Experiments were performed in duplicate for each isolate.
RESULTS

Phenotypic characterization
Five isolates produced morphologically similar flat, butyrous and creamy colonies on potato dextrose agar, whilst one isolate (strain STC4, subgroup B) grew dry and wrinkled colonies. Identification using an ID32 C test kit revealed similar carbohydrate assimilation profiles (code 1300310015) for the six isolates and identified the isolates as C. rugosa. The isolates were differentiated into two subgroups based on their pigmentation on OCCA. Strains STC1-3 (designated subgroup A) developed darker green colonies compared with the rest of the isolates (designated subgroup B). All isolates were able to grow at 25, 30, 35 and 42 u C but not at 45 u C.
Enzymic characterization
Identical enzymic profiles were obtained by API ZYM analysis for a representative isolate from each subgroup in this study, with the detection of alkaline phosphatase, esterase, leucine arylamidase, acid phosphatase, esterase lipase and lipase (C14) from the isolates. Proteinase production was detected from all isolates on proteinase clearance agar after 7 days of incubation.
Sequence analysis of the D1/D2 domain
A total of 466 and 467 nt were determined for the D1/D2 domain of subgroup A isolates (accession no. HQ412589) and subgroup B isolates (accession no. HQ412590), respectively. There was no mismatch in the D1/D2 domain within the subgroups. Table 3 shows a summary of the sequence analysis. Other than the difference in sequence length, the two subgroups differed by three mismatches. Subgroup A isolates demonstrated 99.1 % (four mismatches) nucleotide similarity with the C. rugosa ATCC 10571 type strain, whilst subgroup B isolates demonstrated 99.6 % (two mismatches including an insertion) nucleotide This study
Closely related subgroups of Candida rugosa similarity with the ATCC strain. Subgroups A and B demonstrated 94.4 % (27 mismatches) and 94.6 % (25 mismatches) nucleotide similarity with C. pseudorugosa strain XH1164, the closest relative of C. rugosa. A search in GenBank showed that the closest match (100 %) of subgroup A was with several environmental C. rugosa isolates, and subgroup B with a few unspeciated Candida species from clinical sources ( Table 2) . The phylogenetic tree shown in Fig. 1(a) confirmed the clustering of the isolates with the C. rugosa ATCC 10571 strain and the close relatedness of our isolates with other C. rugosa isolates available in GenBank (Table 2 ).
Sequence analysis of the ITS sequence data
A total of 351 and 352 nt were determined for the ITS gene region of C. rugosa subgroup A (STC1) and B (STC4) isolates, respectively. There was no mismatch in the ITS region sequences within each subgroup. Other than the difference in sequence length, the two subgroups differed by 37 nt. The similarity among the two subgroups as determined by pairwise alignment was 90.1 %. Sequence analysis of the ITS region sequences showed 89.2 % (29 mismatches and one deletion) and 93.7 % (20 mismatches) nucleotide similarity of subgroup A and B isolates with C. rugosa ATCC 10571, respectively (Table 3) . Subgroups A and B demonstrated 79.5 % (71 mismatches) and 81.3 % (65 mismatches) nucleotide similarity with C. pseudorugosa XH1164, the closest relative of C. rugosa (Table 3) . Fig. 1(b) shows a dendrogram demonstrating the genetic relationship of our isolates based on ITS gene sequences of Candida reference strains and C. rugosa isolates documented in GenBank. The ITS sequences of C. rugosa subgroup A isolates showed 100 % similarity only to the environmental isolates. The sequences of the subgroup B isolates matched (100 %) that of a C. rugosa blood isolate (strain UOA/HCPF 2) and a series of clinical isolates (from blood and pericatheter and rectal swabs) from Brazil ( Table 2 ). The two subgroups clustered at two different branches of the ITS phylogenetic tree with a high bootstrap value (100 %). 
Determination of planktonic and biofilm MICs
DISCUSSION
The six Malaysian isolates appeared to be identical phenotypically based on carbohydrate assimilation profiles (API 20C AUX and ID 32 C kits), reactions on chromogenic agar (with one subgroup exhibiting more intense pigmentation), growth temperatures and enzymic characterization. Different colonial morphologies have been described for C. rugosa on CHROMagar, which include the description of rough, dry, flat colonies with a pale border resembling Candida krusei (Hospenthal et al., 2002) and small, dry colonies of a brilliant blue colour with a pale or white border indistinguishable from those of Candida albicans (Horvath et al., 2003) . In this study, only one of the six isolates produced morphologically dry colonies on both potato dextrose agar and OCCA (Table  1) . Based on the growth morphology and their ability to grow at 42 u C, these isolates (particularly subgroup B) may be mistaken for C. albicans if the results of germ tube and other biochemical tests are not available.
Data on the epidemiology and antifungal susceptibilities of this emerging yeast pathogen are scanty. C. rugosa has been isolated most frequently from blood in outbreak situations (Behera et al., 2010; Colombo et al., 2003; Dubé et al., 1994; Singh et al., 2011) and other specimens including respiratory, skin, soft tissue and genital specimens in case reports of single cases (Minces et al., 2009; Pfaller et al., 2006) . As the six isolates investigated in this study were isolated only once from our patients, this may not be sufficient for definite confirmation of their pathogenic roles, particularly for those obtained from non-sterile body sites. The origin of four of the six isolates (two from each subgroup) from blood and urine specimens in this study suggests a similarity to previous findings where C. rugosa was isolated most often from bloodstream and urinary tract infections (Minces et al., 2009; Pfaller et al., 2006) . Interestingly, five of the six isolates were obtained from elderly patients (.60 years old) in this study. This finding is similar to that reported by Colombo et al. (2003) , where the patients in five out of six C. rugosa cases in Brazil were .65 years old, suggesting that older individuals are at higher risk of infection with C. rugosa.
The high level (¢1 mg ml
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) of MICs of amphotericin for four of our isolates is a typical feature of C. rugosa (Minces et al., 2009 ). In addition, treatment failures with polyene agents have been reported, with isolates demonstrating in vitro susceptibility to amphotericin B (Behera et al., 2010; Colombo et al., 2003) . Decreased susceptibility to fluconazole (40.5 % susceptible) was observed particularly among Asian-Pacific and Latin American isolates (Pfaller et al., 2006) . Singh et al. (2011) reported that 16 % of their C. rugosa isolates were resistant to fluconazole compared with 12.5 % of Candida glabrata isolates and ,10 % of Candida tropicalis and Candida parapsilosis isolates.
Bloodstream isolates have been reported to be the least susceptible to fluconazole (Pfaller et al., 2006) . In this study, two C. rugosa blood isolates, STC1 and STC2, were considerably less susceptible to fluconazole (MICs of 32 and 4 mg ml
, respectively) than those from other specimen types (Table 1 ). The susceptibility pattern of our C. rugosa isolates was therefore similar to that of C. glabrata and C. krusei, which are less susceptible to fluconazole and amphotericin B than most other species of Candida (Pfaller & Diekema, 2004) . Hence, accurate identification and antifungal susceptibility testing of the yeast may have a significant impact on the antifungal therapy of C. rugosa infections.
Detection of the proteinase activity from the isolates in this study suggests the potential of the isolates to cause infection, as proteinase is generally known to facilitate microbial adhesion and tissue invasion and has been identified as one of the major pathogenic determinants (Naglik et al., 2003) . Identical enzymic profiles by API ZYM analysis were found for the two subgroups in this study. The enzymes detected include alkaline phosphatase, Fig. 1 . Neighbour-joining tree based on the D1/ D2 domain (a) or the ITS gene region (b) depicting the relationship of C. rugosa subgroups A and B with other yeasts. The estimated confidence levels, expressed as percentages, were determined by bootstrap analysis with 1000 replications. Reference sequences were retrieved from GenBank (Table 2) .
esterase, leucine arylamidase, acid phosphatase, esterase lipase and lipase. Of these enzymes, lipase has been postulated to facilitate proliferation of the yeast in lipidrich environments such as total parenteral nutrition (Minces et al., 2009) .
Infections caused by C. rugosa are usually seen in patients within medical and surgical inpatient services and are associated with the use of central venous catheters and parenteral nutrition (Minces et al., 2009) . Our finding of the ability of the isolates to form biofilms in vitro on plastic surfaces is probably correlated with previous reports of the association of C. rugosa with catheter-related infections and resistance against therapy (Colombo et al., 2003; Minces et al., 2009; Rosas et al., 2004) . The increased resistance to amphotericin (MIC ¢8 mg ml
) and fluconazole (MIC ¢128 mg ml
) of the sessile cells compared with planktonic cells is similar to the observation for other Candida species at the biofilm stage (Ramage et al., 2001 ).
The organisms identified in this study are among a number of novel yeast species in clinical specimens that cannot be distinguished phenotypically from an existing species and rely on a molecular approach for identification (Ciardo et al., 2006) . The D1/D2 domain and ITS sequences of our isolates do not match any known yeast species in GenBank or the CBS yeast sequence database (http://www.cbs.knaw. nl/collections/). Kurtzman & Robnett (1997) predicted that yeast strains showing .1 % substitutions in the~600 nt D1/D2 domain are likely to be different species and that strains with 0-3 nt mismatches are either conspecific or sister species. Hence, based on this correlation, subgroup B (with two mismatches compared with the type strain) is most probably conspecific with C. rugosa.
Although subgroup A had only 0.9 % substitutions in its D1/D2 domain (four mismatches) compared with the type strain, the greater ITS sequence variability (10.8 %) of this subgroup supports the suggestion that the yeast be recognized as a distinct species, as the percentage intraspecies similarity reported previously for C. rugosa is 94.5-100 % (Ciardo et al., 2006) . However, the predicted conspecificity and proposal of a novel Candida species will require more detailed taxonomic reassessment using DNA-DNA hybridization assays (Kurtzman & Robnett, 1997) or other more sophisticated molecular approaches.
The source of C. rugosa is unknown. The yeast is frequently isolated from the milk of mastitic cows (Crawshaw et al., 2005) and its lipase has been used for food production (Benjamin & Pandey, 1998) . Hence, contaminated milk or food products have been speculated as a source of infection (Barton, 2011) . Sequence comparison in this study demonstrated the association of subgroup A isolates (only reported from environmental sources so far) with human infections for the first time, following identification of the isolates from different clinical specimens (blood, urine and bronchoalveolar lavage) in this study. Isolation of the subgroup B isolates from various clinical specimens in this and other studies (as documented in GenBank) is an indication of the emergence of this yeast as a human pathogen in various geographical regions.
Over the past few years, several new and emerging yeast pathogens misidentified using conventional chemotaxonomic criteria have been reported by sequence analysis of the D1/D2 domain and ITS sequences. Molecular techniques have assisted in the identification of C. pseudorugosa (Li et al., 2006) and Candida pararugosa (Ciardo et al., 2006) , which were misidentified previously as C. rugosa using phenotypic methods. In this and the abovementioned studies, the ITS region has been shown to be a valuable region for differentiation of closely related subgroups of C. rugosa (tentatively referred to as the C. rugosa complex). Further clarification of the complex taxonomy of C. rugosa will assist in our understanding of the epidemiology and clinical significance of this yeast.
